SG3 Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

SG3 Management’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-40,000	Closed	-$398K	–	736
2022 Q1	$398K	Sell	40,000 -15,000	-27%	-$159K	0.11%	654
2021 Q4	$647K	Buy	+55,000	New	+$676K	0.07%	579
2021 Q3	–	Sell	-15,000	Closed	-$209K	–	1296
2021 Q2	$209K	Sell	15,000 -56,800	-79%	-$863K	0.09%	820
2021 Q1	$1.33M	Buy	71,800 +41,800	+139%	+$855K	0.43%	521
2020 Q4	$530K	Buy	30,000 +15,000	+100%	+$263K	0.08%	717
2020 Q3	$230K	Buy	+15,000	New	+$282K	0.11%	708

Other funds holding KNSA

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Hudson Bay Capital Management

Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return